Monomeric C-reactive protein as a biomarker for major depressive disorder

Monomeric C-reactive protein as a biomarker for major depressive disorder

Blog Article

Neuroinflammation has been postulated to be a key factor in the pathogenesis of major depressive disorder (MDD).With this is mind, there has been a wave of research looking into pro-inflammatory mediators as potential biomarkers for MDD.One Échanges entre étrangers et natifs. Le réseau de contacts de Johann Friedrich Armand von Uffenbach à Paris such mediator is the acute phase protein, C-reactive protein (CRP).While several studies have investigated the potential of CRP as a biomarker for MDD, the results have been inconsistent.One explanation for the lack of consistent findings may be that the high-sensitivity CRP tests utilized in these studies Clinical and epidemiological characteristics in Seychelles patients diagnosed with dementia only measure the pentameric isoform of CRP (pCRP).

Recent research, however, has indicated that the monomeric isoform of CRP (mCRP) is responsible for the pro-inflammatory function of CRP, while pCRP is weakly anti-inflammatory.The objective of this minireview is to re-examine the evidence of CRP involvement in MDD with a view of mCRP as a potential biomarker.